Catalog No.
YVV00701
Expression system
E. coli
Species
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Protein length
Arg101-Gln222
Predicted molecular weight
15.84 kDa
Nature
Recombinant
Endotoxin level
Please contact with the lab for this information.
Purity
>90% as determined by SDS-PAGE.
Accession
P0DTC5
Applications
ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Form
Lyophilized
Storage buffer
Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.
Reconstitution
Reconstitute in sterile water for a stock solution.
Shipping
In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Alternative Names
Membrane protein, M, E1 glycoprotein, Matrix glycoprotein, Membrane glycoprotein, M Protein
Influence of HLA Class I and II Polymorphisms on COVID-19 Severity in a South Brazilian Population., PMID:40508150
Single-particle quantification of SARS-CoV-2 virus-like particles using flow virometry., PMID:40483334
Case Report: Co-occurrence of tubulitis and SARS-CoV-2 specific T-cells in a kidney transplant recipient., PMID:40343198
Patients With Mild COVID-19 Exhibit Low Functional Avidity of SARS-CoV-2 Membrane Protein-Reactive CD4+ T Cells., PMID:40342838
Membrane Protein of SARS-CoV-2 Promotes the Production of CXCL10 and Apoptosis of Myocardial Cells., PMID:40293660
SARS-CoV-2 Membrane Protein Induces MARCHF1/GPX4-Mediated Ferroptosis by Promoting Lipid Accumulation., PMID:40186530
A coronavirus assembly inhibitor that targets the viral membrane protein., PMID:40140569
A small-molecule SARS-CoV-2 inhibitor targeting the membrane protein., PMID:40140563
Nightlife and low immunity drove transmission of SARS-CoV-2 gamma in Luxembourg, 2021., PMID:40133357
Characteristics of Streptococcus pyogenes causing invasive infections among adults in Portugal, 2016-2019: Pre-COVID-19 expansion of the M1UK sublineage., PMID:40021403
Streptococcus pyogenes emm Type 3.93 Emergence, the Netherlands and England., PMID:39983683
SARS-CoV-2 membrane protein induces neurodegeneration via affecting Golgi-mitochondria interaction., PMID:39726060
TRIM7 ubiquitinates SARS-CoV-2 membrane protein to limit apoptosis and viral replication., PMID:39616206
Design, Development and Immunogenicity Study of a Multi-Epitope Vaccine Prototype Against SARS-CoV-2., PMID:39598409
Direct lipid interactions control SARS-CoV-2 M protein conformational dynamics and virus assembly., PMID:39574576
Assessment of Single-Cycle M-Protein Mutated Vesicular Stomatitis Virus as a Safe and Immunogenic Mucosal Vaccine Platform for SARS-CoV-2 Immunogen Delivery., PMID:39526809
MDA5 Is a Major Determinant of Developing Symptoms in Critically Ill COVID-19 Patients., PMID:39460899
M protein ectodomain-specific immunity restrains SARS-CoV-2 variants replication., PMID:39416782
SARS-CoV-2 N protein coordinates viral particle assembly through multiple domains., PMID:39412257
Unraveling the role of the nucleocapsid protein in SARS-CoV-2 pathogenesis: From viral life cycle to vaccine development., PMID:39216563
T-Cell Epitope Mapping of SARS-CoV-2 Reveals Coordinated IFN-γ Production and Clonal Expansion of T Cells Facilitates Recovery from COVID-19., PMID:39066169
A Comparative Experimental and Computational Study on the Nature of the Pangolin-CoV and COVID-19 Omicron., PMID:39062780
SARS-CoV-2-related peptides induce endothelial-to-mesenchymal transition in endothelial capillary cells derived from different body districts: focus on membrane (M) protein., PMID:38953987
TRIM7 ubiquitinates SARS-CoV-2 membrane protein to limit apoptosis and viral replication., PMID:38948778
Co-Mutations and Possible Variation Tendency of the Spike RBD and Membrane Protein in SARS-CoV-2 by Machine Learning., PMID:38731879
The hinge-engineered IgG1-IgG3 hybrid subclass IgGh47 potently enhances Fc-mediated function of anti-streptococcal and SARS-CoV-2 antibodies., PMID:38678029
Major Role of S-Glycoprotein in Providing Immunogenicity and Protective Immunity in mRNA Lipid Nanoparticle Vaccines Based on SARS-CoV-2 Structural Proteins., PMID:38675761
Influence of Mutations and N-Glycosylation Sites in the Receptor-Binding Domain (RBD) and the Membrane Protein of SARS-CoV-2 Variants of Concern on Antibody Binding in ELISA., PMID:38666819
Extracellular vesicles derived from SARS-CoV-2 M-protein-induced triple negative breast cancer cells promoted the ability of tissue stem cells supporting cancer progression., PMID:38515582
Coronavirus hijacks STX18-ATG14 axis-regulated lipophagy to evade an anti-viral effect., PMID:38477940
SARS-CoV-2 Membrane protein regulates the function of Spike by inhibiting its plasma membrane localization and enzymatic activity of Furin., PMID:38430890
Synthesis, insertion, and characterization of SARS-CoV-2 membrane protein within lipid bilayers., PMID:38416838
Coronavirus M Protein Trafficking in Epithelial Cells Utilizes a Myosin Vb Splice Variant and Rab10., PMID:38247817
SARS-CoV-2 membrane protein-specific antibodies from critically ill SARS-CoV-2-infected individuals interact with Fc receptor-expressing cells but do not neutralize the virus., PMID:38245016
The Antiviral Activity of the Lectin Griffithsin against SARS-CoV-2 Is Enhanced by the Presence of Structural Proteins., PMID:38140693
Negative impact of immunoparesis in response to anti-SARS-CoV-2 mRNA vaccination of patients with multiple myeloma., PMID:38082201
NLRP12 Senses the SARS-CoV-2 Membrane Protein and Promotes an Inflammatory Response., PMID:37976229
A new multi-epitope vaccine candidate based on S and M proteins is effective in inducing humoral and cellular immune responses against SARS-CoV-2 variants: an in silico design approach., PMID:37874075
MERS-CoV and SARS-CoV-2 membrane proteins are modified with polylactosamine chains., PMID:37800895
Current state-of-the-art and potential future therapeutic drugs against COVID-19., PMID:37691829
Differential Severe Acute Respiratory Syndrome Coronavirus 2-Specific Humoral Response in Inactivated Virus-Vaccinated, Convalescent, and Breakthrough-Infected Subjects., PMID:37572355
[Molecular epidemiological analysis of SARS-CoV-2 genovariants in Moscow and Moscow region]., PMID:37264839
Molecular Epidemiology of SARS-CoV-2 during Five COVID-19 Waves and the Significance of Low-Frequency Lineages., PMID:37243279
Perturbation of the host cell Ca2+ homeostasis and ER-mitochondria contact sites by the SARS-CoV-2 structural proteins E and M., PMID:37120609
Seasonal effects decouple SARS-CoV-2 haplotypes worldwide., PMID:37069849
Variants of SARS-CoV-2: Influences on the Vaccines' Effectiveness and Possible Strategies to Overcome Their Consequences., PMID:36984508
Crystal structure of the membrane (M) protein from a bat betacoronavirus., PMID:36874273
Molecular architecture and dynamics of SARS-CoV-2 envelope by integrative modeling., PMID:36870335
Emerging trends in point-of-care biosensing strategies for molecular architectures and antibodies of SARS-CoV-2., PMID:36844889
Immune profiling of SARS-CoV-2 epitopes in asymptomatic and symptomatic pediatric and adult patients., PMID:36788606
For research use only. Not for human or drug use.
